Abiopharma

Clinical trial NCT07213960 updates: 1. status: NOT_YET_RECRUITING → SUSPENDED 2. start date: 2025-12-01 → 2026-12-01

Clinical trial NCT04419402 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2025-01-01 → 2026-12-01 3. primary completion date: 2024-07-31 → 2024-04-12

Clinical trial NCT04934787 updates: 1. completion date: 2025-12-01 → 2027-12-31 2. primary completion date: 2025-12-01 → 2027-12-31

Clinical trial NCT07634471: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT07159763 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-01-01 → 2027-06-01 3. primary completion date: 2027-01-01 → 2027-06-01 4. enrollment: 7500 → 10000 participants

Clinical trial NCT06351592 updates: 1. completion date: 2031-06-05 → 2032-03-21 2. primary completion date: 2031-06-05 → 2032-03-21 3. enrollment: 42 → 54 participants

Clinical trial NCT06785038: completion date: 2026-07-31 → 2027-01-31.

Clinical trial NCT05637099 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-04-29 3. enrollment: 266 → 181 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07011771 updates: 1. status: SUSPENDED → WITHDRAWN 2. completion date: 2029-11-01 → 2026-06-17 3. primary completion date: 2029-09-01 → 2026-06-17 4. enrollment: 31 → 0 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05325866: status: COMPLETED → TERMINATED.